Stock data
IGC Pharma, Inc. (IGC)
IGC Pharma, Inc. (IGC) reported revenue of US$1.27M and net income of -US$7.12M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-03-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$1.27M | US$0.62M | -US$7.45M | -US$7.12M | — |
| 2024 | US$1.34M | US$0.73M | -US$9.80M | -US$13.00M | — |
| 2023 | US$0.91M | US$0.44M | -US$11.57M | -US$11.51M | — |
| 2022 | US$0.40M | US$0.19M | -US$15.43M | -US$15.02M | — |
| 2021 | US$0.90M | US$0.11M | -US$8.72M | -US$8.81M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$0.27M | -US$2.94M | — |
| 2026-03-31 | US$0.32M | -US$2.40M | — |
| 2025-09-30 | US$0.19M | -US$1.82M | — |
| 2025-06-30 | US$0.33M | -US$1.60M | — |
| 2025-03-31 | US$0.33M | -US$1.20M | — |
| 2024-12-31 | US$0.26M | -US$1.83M | — |
| 2024-09-30 | US$0.41M | -US$1.72M | — |
| 2024-06-30 | US$0.27M | -US$2.38M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.